News > Non-statin cholesterol-lowering drugs linked to lower liver cancer risk

Non-statin cholesterol-lowering drugs linked to lower liver cancer risk

The study, led by the National Cancer Institute of the Maryland National Institute of Health, focussed on five types of non-statin cholesterol-lowering drugs: Cholesterol absorption inhibitors, bile acid sequestrants, fibrates, niacin, and omega-3 fatty acids. Researchers included 3,719 liver cancer cases and 14,876 matched controls without cancer. The study also accounted for variables like type 2 diabetes and chronic liver disease status.